Summit Therapeutics Inc [NASDAQ: SMMT] traded at a high on Wednesday, posting a 21.50 gain after which it closed the day’ session at $33.23.
The results of the trading session contributed to over 11767384 shares changing hands. Over the past one week, the price volatility of Summit Therapeutics Inc stands at 10.31% while the volatility over the past one month is 11.05%.
The market cap for SMMT stock reached $24.51 billion, with 737.63 million shares outstanding and 111.14 million shares in the current float. Compared to the average trading volume of 2.93M shares, SMMT reached a trading volume of 11767384 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Summit Therapeutics Inc [SMMT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SMMT shares is $35.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SMMT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Summit Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 26, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on March 21, 2025, representing the official price target for Summit Therapeutics Inc stock. Previously, the target price had yet another raise to $30, while Evercore ISI analysts kept a Outperform rating on SMMT stock.
The Average True Range (ATR) for Summit Therapeutics Inc is set at 2.42 The Price to Book ratio for the last quarter was 63.05, with the Price to Cash per share for the same quarter was set at 0.56.
How has SMMT stock performed recently?
Summit Therapeutics Inc [SMMT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.97. With this latest performance, SMMT shares gained by 60.61% in over the last four-week period, additionally plugging by 56.67% over the last 6 months – not to mention a rise of 849.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SMMT stock in for the last two-week period is set at 75.54, with the RSI for the last a single of trading hit 80.89, and the three-weeks RSI is set at 71.30 for Summit Therapeutics Inc [SMMT]. The present Moving Average for the last 50 days of trading for this stock 20.61, while it was recorded at 26.69 for the last single week of trading, and 18.32 for the last 200 days.
Summit Therapeutics Inc [SMMT]: Deeper insight into the fundamentals
Summit Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.15 and a Current Ratio set at 10.15.
Earnings analysis for Summit Therapeutics Inc [SMMT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SMMT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Summit Therapeutics Inc go to -28.25%.
Insider trade positions for Summit Therapeutics Inc [SMMT]
There are presently around $12.92%, or 82.62%% of SMMT stock, in the hands of institutional investors. The top three institutional holders of SMMT stocks are: BAKER BROS. ADVISORS LP with ownership of 23.22 million shares, which is approximately 3.2804%. VANGUARD GROUP INC, holding 8.82 million shares of the stock with an approximate value of $$68.78 million in SMMT stocks shares; and VANGUARD GROUP INC, currently with $$61.61 million in SMMT stock with ownership which is approximately 1.1158%.
